Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
EV/EBITDA
52.17 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Progenics Pharmaceuticals Inc's enterprise value is $416.56 Mil. Progenics Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2014 was $7.99 Mil. Therefore, Progenics Pharmaceuticals Inc's EV/EBITDA ratio for today is 52.17.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Progenics Pharmaceuticals Inc's stock price is $7.25. Progenics Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2014 was $0.05. Therefore, Progenics Pharmaceuticals Inc's P/E Ratio for today is 145.00.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Progenics Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=416.562/7.985
=52.17

Progenics Pharmaceuticals Inc's current Enterprise Value is $416.56 Mil.
Progenics Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was -8.758 (Dec. 2013 ) + -9.181 (Mar. 2014 ) + -10.954 (Jun. 2014 ) + 36.878 (Sep. 2014 ) = $7.99 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Progenics Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=7.25/0.05
=145.00

Progenics Pharmaceuticals Inc's share price for today is $7.25.
Progenics Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was -0.14 (Dec. 2013 ) + -0.15 (Mar. 2014 ) + -0.17 (Jun. 2014 ) + 0.51 (Sep. 2014 ) = $0.05.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda -6.62-6.60-19.66-8.45-4.34-1.81-1.9817.68-2.34-6.15

Progenics Pharmaceuticals Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2ebitda -6.40-1.27-2.34-6.76-5.47-6.89-6.15-4.62-5.4734.78
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK